Skip to main content
. Author manuscript; available in PMC: 2014 May 15.
Published in final edited form as: Am J Cardiol. 2013 Feb 20;111(10):1437–1442. doi: 10.1016/j.amjcard.2013.01.297

Table 2.

Descriptive Statistics, Overall and by Statin MPR, 2008–2011

Statin MPR

Variable <80%
(N=639)
80%+
(N=143)
Overall
(N=782)
p-value
Female 353 (55%) 73 (51%) 426 (55%) 0.36
Male 286 (45%) 70 (49%) 356 (46)
Age at 1st Rx Fill
Mean (SD)
52 (8) 55 (7) 53 (8) <0.01
White 135 (21%) 50 (36%) 185 (24%) <0.01
Black 258 (41%) 42 (30%) 300 (39%)
Hispanic 122 (19%) 18 (13%) 140 (18%)
Other 118 (19%) 31 (22%) 149 (19%)
Number of outpatient visits
Mean (SD)
45 (41) 47 (44) 46 (42) 0.96
Diagnoses
Diabetes mellitus 422 (66%) 90 (63%) 512 (66%) 0.48
Ischemic heart disease 137 (21%) 31 (22%) 168 (22%) 0.95
Hypertension 568 (89%) 130 (91%) 698 (89%) 0.48
Chronic liver disease 33 (5%) 10 (7%) 43 (6%) 0.39
Cerebrovascular disease 62 (10%) 14 (10%) 76 (10%) 0.97
Framingham risk index
Mean (SD)
0.18 (0.13) 0.19 (0.13) 0.18 (0.13) 0.24
Number of LDL
measurements
Mean (SD)
4.6 (1.8) 4.5 (1.8) 4.6 (1.8 0.36
Within patient mean LDL
Mean (SD)
112 (33) 96 (29) 109 (33) <0.01
Number of days between
1st and last fill dates
Mean (SD)
1000 (338) 968 (418) 994 (354) 0.97